ImmunityBio, Inc.
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulato…
Biotechnology
US, San Diego [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
ImmunityBio, Inc. can't present it's latest revenue by geo. area
Revenue By Geographic Areas
ImmunityBio, Inc. can't present it's latest revenue by geo. area
Historical Revenue By Segment
Last 3Y, in mil. USDImmunityBio, Inc. can't present revenue by segment
Historical Revenue By Geographic Area
Last 3Y, in mil. USDImmunityBio, Inc. can't present revenue by geo. area